Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Sanara MedTech (SMTI) over the last 15 years, with Q3 2025 value amounting to -$31.2 million.

  • Sanara MedTech's Net Income towards Common Stockholders fell 105618.36% to -$31.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$43.5 million, marking a year-over-year decrease of 42411.28%. This contributed to the annual value of -$9.8 million for FY2024, which is 12121.86% down from last year.
  • As of Q3 2025, Sanara MedTech's Net Income towards Common Stockholders stood at -$31.2 million, which was down 105618.36% from -$1.8 million recorded in Q2 2025.
  • Over the past 5 years, Sanara MedTech's Net Income towards Common Stockholders peaked at -$262444.0 during Q4 2023, and registered a low of -$31.2 million during Q3 2025.
  • In the last 5 years, Sanara MedTech's Net Income towards Common Stockholders had a median value of -$2.0 million in 2021 and averaged -$4.0 million.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first skyrocketed by 9369.65% in 2023, then tumbled by 256839.06% in 2024.
  • Over the past 5 years, Sanara MedTech's Net Income towards Common Stockholders (Quarter) stood at -$3.6 million in 2021, then dropped by 17.06% to -$4.2 million in 2022, then skyrocketed by 93.7% to -$262444.0 in 2023, then tumbled by 2568.39% to -$7.0 million in 2024, then plummeted by 346.19% to -$31.2 million in 2025.
  • Its last three reported values are -$31.2 million in Q3 2025, -$1.8 million for Q2 2025, and -$3.4 million during Q1 2025.